Enzymatic treatment of retinitis pigmentosa and relevant...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/06 (2006.01) A61K 31/7084 (2006.01)

Patent

CA 2567205

A kit for the treatment of retinitis pigmentosa containing the coenzymes Reduced nicotinamide adenine dinucleotide (NADH), Reduced Nicotinamide adenine dinucleotide phosphate (NADPH) and Reduced Glutathione in aliquot parts and interactive quantities appropriate for administering said enzymes in accordance with a predefined time sequence.

L'invention concerne un nécessaire de traitement de la rétinite pigmentaire contenant des coenzymes de nicotinamide-adénine-dinucléotide réduit (NADH) ou de nicotinamide-adénine-dinucléotide-phosphate réduit (NADPH) et de glutathione réduit en parties aliquotes et en quantités interactives appropriées en vue d'une administration de ces enzymes en fonction d'une séquence temporelle prédéfinie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enzymatic treatment of retinitis pigmentosa and relevant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzymatic treatment of retinitis pigmentosa and relevant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic treatment of retinitis pigmentosa and relevant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2071759

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.